{"name":"Sun Pharmaceutical Industries, Inc.","slug":"sun-pharmaceutical-industries-inc","ticker":"","exchange":"","domain":"sunpharma.com","description":"","hq":"Mumbai","founded":0,"employees":"","ceo":"Dilip Shanghvi","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"cardiovascular","drugs":[{"name":"Desoximetasone 0.05% twice daily","genericName":"Desoximetasone 0.05% twice daily","slug":"desoximetasone-0-05-twice-daily","indication":"Other","status":"phase_2"},{"name":"Desoximetasone 0.25% once daily","genericName":"Desoximetasone 0.25% once daily","slug":"desoximetasone-0-25-once-daily","indication":"Other","status":"phase_2"},{"name":"Malathion gel 0.5%","genericName":"Malathion gel 0.5%","slug":"malathion-gel-0-5","indication":"Head lice infestation (pediculosis capitis)","status":"phase_3"},{"name":"Ovide (malathion) lotion 0.05%","genericName":"Ovide (malathion) lotion 0.05%","slug":"ovide-malathion-lotion-0-05","indication":"Treatment of head lice infestations","status":"phase_3"},{"name":"Ruxolitinib Topical Cream 1.5%","genericName":"Ruxolitinib Topical Cream 1.5%","slug":"ruxolitinib-topical-cream-1-5","indication":"Other","status":"phase_1"},{"name":"Topical TA-102 D","genericName":"Topical TA-102 D","slug":"topical-ta-102-d","indication":"Other","status":"phase_1"},{"name":"Lotrimin Ultra®","genericName":"Lotrimin Ultra®","slug":"lotrimin-ultra","indication":"Tinea pedis (athlete's foot)","status":"marketed"},{"name":"Permethrin 1% rinse","genericName":"Permethrin 1% rinse","slug":"permethrin-1-rinse","indication":"Treatment and prevention of head lice infestations","status":"phase_3"},{"name":"Placebo topical cream","genericName":"Placebo topical cream","slug":"placebo-topical-cream","indication":"Other","status":"marketed"},{"name":"TA103","genericName":"TA103","slug":"ta103","indication":"Other","status":"phase_1"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"Desoximetasone Spray 0.25%","genericName":"Desoximetasone Spray 0.25%","slug":"desoximetasone-spray-0-25","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)","status":"marketed"},{"name":"ADPS topical product","genericName":"ADPS topical product","slug":"adps-topical-product","indication":"Psoriasis","status":"phase_2"},{"name":"DSXS topical product","genericName":"DSXS topical product","slug":"dsxs-topical-product","indication":"Seborrheic dermatitis","status":"phase_2"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"DSXS topical","genericName":"DSXS topical","slug":"dsxs-topical","indication":"Dermatological indication (specific indication not publicly disclosed)","status":"phase_3"},{"name":"Onexton™ Gel","genericName":"Onexton™ Gel","slug":"onexton-gel","indication":"Acne vulgaris","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DSXS","genericName":"DSXS","slug":"dsxs","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Naftifine Hydrochloride Cream 2%","genericName":"Naftifine Hydrochloride Cream 2%","slug":"naftifine-hydrochloride-cream-2","indication":"Tinea pedis (athlete's foot)","status":"phase_3"}]}],"pipeline":[{"name":"DSXS","genericName":"DSXS","slug":"dsxs","phase":"phase_3","mechanism":"DSXS is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"DSXS topical","genericName":"DSXS topical","slug":"dsxs-topical","phase":"phase_3","mechanism":"DSXS is a topical formulation designed to deliver active pharmaceutical ingredients to skin lesions or dermatological conditions through enhanced penetration.","indications":["Dermatological indication (specific indication not publicly disclosed)"],"catalyst":""},{"name":"Desoximetasone 0.05% twice daily","genericName":"Desoximetasone 0.05% twice daily","slug":"desoximetasone-0-05-twice-daily","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Desoximetasone 0.25% once daily","genericName":"Desoximetasone 0.25% once daily","slug":"desoximetasone-0-25-once-daily","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Desoximetasone Spray 0.25%","genericName":"Desoximetasone Spray 0.25%","slug":"desoximetasone-spray-0-25","phase":"marketed","mechanism":"Desoximetasone is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"],"catalyst":""},{"name":"Malathion gel 0.5%","genericName":"Malathion gel 0.5%","slug":"malathion-gel-0-5","phase":"phase_3","mechanism":"Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites.","indications":["Head lice infestation (pediculosis capitis)","Scabies (Sarcoptes scabiei infestation)"],"catalyst":""},{"name":"Naftifine Hydrochloride Cream 2%","genericName":"Naftifine Hydrochloride Cream 2%","slug":"naftifine-hydrochloride-cream-2","phase":"phase_3","mechanism":"Naftifine is a fungistatic agent that inhibits fungal sterol synthesis by blocking squalene epoxidase, disrupting the fungal cell membrane.","indications":["Tinea pedis (athlete's foot)","Tinea cruris (jock itch)","Tinea corporis (ringworm)","Other dermatophyte infections"],"catalyst":""},{"name":"Ovide (malathion) lotion 0.05%","genericName":"Ovide (malathion) lotion 0.05%","slug":"ovide-malathion-lotion-0-05","phase":"phase_3","mechanism":"Ovide (malathion) lotion works by killing lice and their eggs on the scalp.","indications":["Treatment of head lice infestations"],"catalyst":""},{"name":"Ruxolitinib Topical Cream 1.5%","genericName":"Ruxolitinib Topical Cream 1.5%","slug":"ruxolitinib-topical-cream-1-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topical TA-102 D","genericName":"Topical TA-102 D","slug":"topical-ta-102-d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ADPS topical product","genericName":"ADPS topical product","slug":"adps-topical-product","phase":"phase_2","mechanism":"ADPS topical product is a small molecule that targets the skin to treat various conditions.","indications":["Psoriasis"],"catalyst":""},{"name":"DSXS topical product","genericName":"DSXS topical product","slug":"dsxs-topical-product","phase":"phase_2","mechanism":"DSXS topical product is a corticosteroid that reduces inflammation and itching by suppressing the immune system.","indications":["Seborrheic dermatitis","Psoriasis"],"catalyst":""},{"name":"Lotrimin Ultra®","genericName":"Lotrimin Ultra®","slug":"lotrimin-ultra","phase":"marketed","mechanism":"Lotrimin Ultra contains butenafine, an allylamine antifungal that disrupts fungal cell membrane synthesis by inhibiting squalene epoxidase.","indications":["Tinea pedis (athlete's foot)","Tinea cruris (jock itch)","Tinea corporis (ringworm)","Tinea versicolor"],"catalyst":""},{"name":"Onexton™ Gel","genericName":"Onexton™ Gel","slug":"onexton-gel","phase":"phase_3","mechanism":"Onexton is a topical combination gel containing clindamycin and benzoyl peroxide that reduces acne by killing bacteria and decreasing sebum production.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Permethrin 1% rinse","genericName":"Permethrin 1% rinse","slug":"permethrin-1-rinse","phase":"phase_3","mechanism":"Permethrin 1% rinse works by killing or repelling insects and other arthropods through its insecticidal properties.","indications":["Treatment and prevention of head lice infestations","Treatment and prevention of scabies infestations"],"catalyst":""},{"name":"Placebo topical cream","genericName":"Placebo topical cream","slug":"placebo-topical-cream","phase":"marketed","mechanism":"A placebo topical cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":[],"catalyst":""},{"name":"TA103","genericName":"TA103","slug":"ta103","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQRU1pdVJ6ZVZkVnUzMHg5eGt6RXlYQ1NqNFN4dVhXbzN3bWR3U2pMbEFveUZIWGRVdjU1dVNReGsxRnRrUlZWbm5xRDJ3MDZSZDNtSnF1bVVDNlZmc09QUmZKbUR3NFR0SUJMcXp5aEp6clVTQURJNW82TUpMN1ZQbnU4eElXbG9SRU1fN2NOMldBQkNYX2lNV3N5SG9TOGl4SVhuNTBUcHJRMjVSNFdPSjcwZGh1X2ZvNlA3UWN1WFVfV2V1Yi1JZEx6ZnliaWcxd0E?oc=5","date":"2026-04-08","type":"pipeline","source":"scanx.trade","summary":"Sun Pharma Publishes Postal Ballot Newspaper Ads for Director Appointment - scanx.trade","headline":"Sun Pharma Publishes Postal Ballot Newspaper Ads for Director Appointment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"pipeline","source":"Business Standard","summary":"Sun Pharmaceutical Industries Ltd eases for fifth straight session - Business Standard","headline":"Sun Pharmaceutical Industries Ltd eases for fifth straight session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQeVNrVnNQQnM4aURxREdSa29xQXY3T0ZPNl9mSTN2VHhPbWExbFlHRFZiTXJEYmVzOVlfMERUQlJtTTh4bGVhZnlOMnFqd1VtVUhMYUctd0U0VUNlcHp2OEpOQzh5V0YxejlKb2ZXSDNhcEk3ZERQRFNweVo1RHBDanp2dVZXdDhkcG1XUUpxd284MU9UTTFMdUxwQm5lLTBHQzV1c2NaMU9LY3Y0?oc=5","date":"2026-04-06","type":"deal","source":"Markets Mojo","summary":"Sun Pharmaceutical Industries Ltd is Rated Buy - Markets Mojo","headline":"Sun Pharmaceutical Industries Ltd is Rated Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQdjZvSV9rd0tISlJ0U0l5MkdaYURuRmUtTV9NQ0hEeDFJZWJfRl9raGVLcTlsOEgzSlFDdVNzS012S3pSbnNNZE85Z25KT2JvelVjVm5nMXpxbzZ2NEVvZmxZRXh6YU5qNFNjc2xpUVAxbTBoOUhPQkhIX0ZPRVJfMWdmOTAwNTdpeThaSmpNSEVYek9vVGVCcEhzOVhSZ2VQempFNVZ5Ri1nUEJ5cUtzXzBBbUNZRWJVbkRyT2dZcVRCa2tMSHU5RjVHU3c4TFo0MnljaFAtZE5GalBha2R0QTdVN01BWm92WmlnV1I3eGtrdw?oc=5","date":"2026-03-27","type":"pipeline","source":"PR Newswire","summary":"Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting - PR Newswire","headline":"Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPZURLdzMtT3JIMFFTRzhsd21pVWtGZ0dTX0NlMkdLSmJTN0tCR1JzdlpvUFNTUGE2MThoM0tJVUlsZjlHeTU2RkljMnVVZ3RZbzdyal9qUW0zMWJSQWZoOXMzZmFPOGVqTmMyLWRDSkloMzlycWhiQjYwOE5td0F1czh1a1UzS1V3aGtTS3RtUFpPSV9ndnNybDhlel9RWjVHc0ZlTVBKZXlWYXNFWmV1QmtMNWRMQ2c1aG9EMHBvYkt2SXNWQlhra1ZmOGtBcGN5WGQ3VXMwVHp4XzRoUGlyR0hjRXp0SkprR0dOMg?oc=5","date":"2026-02-27","type":"trial","source":"PR Newswire","summary":"Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami - PR Newswire","headline":"Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPVUh2NnhXRjNXZ3l2UE8tRnFVaFBQejFXaTlQOUxkRG4yekR1bHhJdmhGLWJlZlpKWW5VY2kwMzE5WUZsTVZQS1NMbUtKdWNZU0lTNGpNXzV6ZGhjSmF4emFSOWYtSXJCTEY2UjNEREltMXF2UG94Nm9tMTIyNTZTYUN5WFZsRU5HTXZ0cVV4RExLNTAwZGVsYW81cUl6Y3dwX3VwdUF3THpnckZsV0VuRjc4QzFWLWl2bjAzd1RaV2hlbHN2Q2FnZktHUUFmOENuRnpqelpiU2FsSTQ2bmc?oc=5","date":"2026-02-05","type":"pipeline","source":"morningstar.com","summary":"Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care - morningstar.com","headline":"Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBHVUFFRk4xMXUyaXJzUzlWeDNjSkh5UkdZTThKbVZIcWlScmd1aHJ4c1JOb0ZKcDlBRHhmOWZkSDNEdUJpSlExZkhPeDA4UWV1Q0xFdGl2M1ZkRFRET00tSzRtb1kwMXh5VnU1b1NKdmVZaU1FUkM3WERFMHFXZw?oc=5","date":"2026-01-26","type":"pipeline","source":"Yahoo Finance","summary":"China halts sale of Sun Pharma drug used to treat dementia - Yahoo Finance","headline":"China halts sale of Sun Pharma drug used to treat dementia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-01-26","type":"regulatory","source":"The Economic Times","summary":"Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times","headline":"Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOaFFMZ0YwQ0cwZnZUd2ZJaE5lRzZIS09ZZDFYdGstYXRSNXlmeEJzVXpCYTJ5M0laSHc3RU05dHBDMlJBRWcwWUM3UmtnWXdybFdxYUJLbXRSY1RNU2NqVWNMdTZ1elYxLS1CMUJ2Zm1GMXdUMDVaQW1ST0p3M0V0cElWbDNzelRDZktJY0FobWZrS1VKdlZycFNQYm5YcFFNY0hYSThPdnc3Qy1VWXBNOURKVEJ3Zw?oc=5","date":"2026-01-21","type":"pipeline","source":"Bloomberg.com","summary":"India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon - Bloomberg.com","headline":"India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQUWw5dTd1SUM0RVdZby1sMnhfRTd1MUtiNlplc3oyQ254WVg4VVlrZVRubmxKY3pqUzUwNlRCWFpINjRuZGNfeXlwVDJyTUtLRlBod20yT1VoaFRQMVVWRlVjdllKNmRqeThTNjVNanRSd1QyRWVOYjF5Z3JqYmRPaGEybjlUbzNxbnQyelRHOWlDaGRZQ2dZM3llMmo5NjRtNkc4eUNZOXF5QjhhdUY0T195REFyMUhEVVZNag?oc=5","date":"2025-11-05","type":"earnings","source":"Reuters","summary":"India's Sun Pharma beats Q2 profit estimates, targets growth through drug launches - Reuters","headline":"India's Sun Pharma beats Q2 profit estimates, targets growth through drug launches","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNVzJpOUxrMWYtY05uWEI3akdXVllDRkNnUlNUNl9DR2VrbjFxTTZyUF9YSmtvSDB0eFhCRVFIeDJyMk9vcDFUSzlfYkRzeXJ3VHJudjM5bVBVVXR5ejNwZzJOc01ib0VvWkN3cTJKOTdLb0VXSUdhdDZ2RXo0OWFWSDZrVDRqRXU0QklSSkVoaGRsZjdCeDF5SDlPU2JjcERVajctZkluaGducUIxMHBF?oc=5","date":"2025-10-23","type":"pipeline","source":"ROI-NJ","summary":"Allen named VP, corporate affairs for North America at Sun Pharma - ROI-NJ","headline":"Allen named VP, corporate affairs for North America at Sun Pharma - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOejFRMXFCR1hsVVlPZkVHUkk4ZmVRRkl2LV8za01xdm1VUGRZc1BHRU42dEViTW5IbHNpSzIzdE9wX2NLVEl3R0tXa3lPZTNQWEVUQzR4ZFlwSF9MVlJ1V0dmUHM3b3JONlBpMWJya0I1YmhWZHVhc0g3ZG9wQjRYVnY1SXZodWpvbmhvMmM3N3lmSlpmaXJJY0w1UVZVMHprYVRRdVF3RTdZbFFkang3c0FB?oc=5","date":"2025-07-24","type":"patent","source":"Bloomberg.com","summary":"Sun Pharma to Settle US Generics Pricing Case for $200 Million (SUNP) - Bloomberg.com","headline":"Sun Pharma to Settle US Generics Pricing Case for $200 Million (SUNP)","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"phase_3":7,"phase_2":4,"marketed":3,"phase_1":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}